Utomilumab

Item number	Size	Delivery time	Price
TGM-T76705-1mg	1 mg	7 - 10 business days*	295.00€
TGM-T76705-5mg	5 mg	7 - 10 business days*	745.00€
TGM-T76705-10mg	10 mg	7 - 10 business days*	1,181.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Utomilumab (PF 05082566) is a humanized IgG2 antibody that targets the T-cell... more

Close menu

Product information "Utomilumab"

Description: Utomilumab (PF 05082566) is a humanized IgG2 antibody that targets the T-cell co-stimulatory receptor 4-1BB/CD137 and acts as a 4-1BB/CD137 agonist. It exhibits antitumor activity and may be used in the study of patients with advanced malignancies. Target: TNF. References: Ajay K Gopal, et al. First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas. Clin Cancer Res. 2020 Jun 1,26(11):2524-2534.

Keywords:	PF-2566, PF 05082566
Supplier:	TargetMol
Supplier-Nr:	T76705

Properties

Conjugate:	No
MW:	388.42 D
Formula:	C17H24N8O3

Database Information

KEGG ID :	K05146 \| Matching products
UniProt ID :	Q07011 \| Matching products
Gene ID :	GeneID 3604 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Utomilumab"

Write a review